ALK33-001: A Study of RDC-0313 Administered to Healthy Adults

NCT00800319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: RDC-0313
DRUG: Placebo

Sponsor

Alkermes, Inc.